An improving macro picture and less election noise could provide a tailwind for emerging market corporate bonds for the rest of 2024, says Muzinich & Co.
In this podcast, Muzinich & Co. look at the potential scenarios for France to break the deadlock of a hung parliament and explain why investors should care.
The market for Ozempic and similar GLP-1 receptor agonists is booming, driven by their effectiveness in promoting weight loss and addressing other health conditions.
With fears of an economic hard landing abating and rates expected to stay higher for longer, can a greater allocation to high yield boost multi-asset credit returns?
With interest rate volatility likely to continue, Muzinich & Co explains how investors can insulate their credit exposure while potentially generating compelling returns via an allocation to short-duration...
The second round of the French election still delivered a shock result: the far-right National Rally was pushed into third place in a result that triggers days if not weeks of negotiations between the...